|
End-of-day quote
Other OTC
|
||
| - USD | - |
|
| 21/05 | BioRegenx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 16/04 | BioRegenx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 34.01L 30.21L 28.2L 25.7L 48.48L 33Cr 48.93L 3.41Cr 1.32Cr 17Cr 1.28Cr 1.25Cr 54Cr | P/E 2024 |
-0.37x | P/E 2025 | -8.02x |
|---|---|---|---|---|---|
| Enterprise Value | 55.46L 49.27L 45.99L 41.92L 79.05L 53Cr 79.79L 5.57Cr 2.16Cr 27Cr 2.08Cr 2.04Cr 87Cr | EV / Sales 2024 |
4.58x | EV / Sales 2025 | 7.85x |
| Free-Float |
-
| Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
William Resides
CEO | Chief Executive Officer | 57 | 08/03/2024 |
Gary Hennerberg
SEC | Corporate Secretary | 69 | 08/03/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Powers
BRD | Director/Board Member | 71 | 01/01/2012 |
William Resides
BRD | Director/Board Member | 57 | 08/03/2024 |
Suzanne Bird
BRD | Director/Board Member | 61 | 08/03/2024 |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 23.4L 20.79L 19.41L 17.69L 33.36L 22Cr 33.67L 2.35Cr 91L 12Cr 87.86L 85.95L 37Cr | 18.55L 16.48L 15.38L 14.02L 26.44L 18Cr 26.68L 1.86Cr 72.12L 9.11Cr 69.63L 68.12L 29Cr |
| Net income | -2.31Cr -2.05Cr -1.91Cr -1.74Cr -3.29Cr -221.62Cr -3.32Cr -23Cr -8.97Cr -113.3Cr -8.66Cr -8.47Cr -363.61Cr | -15.44L -13.71L -12.8L -11.67L -22L -15Cr -22.21L -1.55Cr -60.03L -7.59Cr -57.95L -56.7L -24Cr |
| Net Debt | 21.06L 18.71L 17.46L 15.92L 30.02L 20Cr 30.3L 2.11Cr 81.89L 10Cr 79.06L 77.35L 33Cr | 21.45L 19.06L 17.79L 16.21L 30.58L 21Cr 30.86L 2.15Cr 83.42L 11Cr 80.54L 78.79L 34Cr |
Employees
-
Sector
-
Select your edition
All financial news and data tailored to specific country editions
















